Immune Reconstitution following Myeloablative Allogeneic Hematopoietic Stem Cell Transplantation: The Impact of Expanding CD28negative CD8+ T Cells on Relapse

Biology of Blood and Marrow Transplantation

Volumn 15, Issue 4, 2009, Pages 496-504

  Yakoub Agha, Ibrahim ^a,b   Saule, Pasquine ^a,b   Magro, Leonardo ^a   Cracco, Pascale ^a   Duhamel, Alain ^c   Coiteux, Valérie ^a   Bruno, Bénédicte ^a   Dufossé, Françoise ^a   Jouet, Jean Pierre ^a,b   Dessaint, Jean Paul ^a,b   Labalette, Myriam ^a,b  

^a LILLE UNIVERSITY HOSPITAL   (France)

^b UNIV LILLE   (France)

^c Faculté de Médecine Pôle Recherché   (France)

Author keywords

Allogeneic stem cell transplantation; CD28; CD8; chronic GVHD; Homeostatic peripheral expansion; Relapse

Indexed keywords

BUSULFAN; CD28 ANTIGEN; CHEMOKINE RECEPTOR CCR7; CYCLOPHOSPHAMIDE;

ADOLESCENT; ADULT; ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION; ARTICLE; CANCER RELAPSE; CD8+ T LYMPHOCYTE; CHILD; CHRONIC GRAFT VERSUS HOST DISEASE; CONTROLLED STUDY; DISEASE FREE SURVIVAL; DONOR LYMPHOCYTE INFUSION; FEMALE; FOLLOW UP; HEMATOLOGIC MALIGNANCY; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; LYMPHOCYTE COUNT; MAJOR CLINICAL STUDY; MALE; NONMYELOABLATIVE STEM CELL TRANSPLANTATION; RECURRENCE RISK;

ADOLESCENT; ADULT; ANTIGENS, CD28; CD8-POSITIVE T-LYMPHOCYTES; CHILD; CHILD, PRESCHOOL; CHRONIC DISEASE; FEMALE; FOLLOW-UP STUDIES; GRAFT VS HOST DISEASE; HEMATOLOGIC NEOPLASMS; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; LYMPHOCYTE COUNT; MALE; MIDDLE AGED; RECEPTORS, CCR7; RECOVERY OF FUNCTION; RECURRENCE; RETROSPECTIVE STUDIES; TIME FACTORS; TRANSPLANTATION CONDITIONING; TRANSPLANTATION, HOMOLOGOUS;

EID: 61849120778     PISSN: 10838791     EISSN: 15236536     Source Type: Journal    
DOI: 10.1016/j.bbmt.2008.11.038     Document Type: Article

References (36)

1. Bleakley M., and Riddell S.R. Molecules and mechanisms of the graft-versus-leukaemia effect. Nat Rev Cancer 4 (2004) 371-380
2. Shlomchik W.D. Graft-versus-host disease. Nat Rev Immunol 7 (2007) 340-352
3. + T-cell regenerative pathways result in prolonged T-cell subset imbalance after intensive chemotherapy. Blood 89 (1997) 3700-3707
4. Storek J., Joseph A., Espino G., et al. Immunity of patients surviving 20 to 30 years after allogeneic or syngeneic bone marrow transplantation. Blood 98 (2001) 3505-3512
5. de Vries E., van Tol M.J., van den Bergh R.L., et al. Reconstitution of lymphocyte subpopulations after paediatric bone marrow transplantation. Bone Marrow Transplant 25 (2000) 267-275
6. Peggs K.S., and Mackinnon S. Immune reconstitution following haematopoietic stem cell transplantation. Br J Haematol 124 (2004) 407-420
7. Williams K.M., Hakim F.T., and Gress R.E. T cell immune reconstitution following lymphodepletion. Semin Immunol 19 (2007) 318-330
8. Goldrath A.W., Luckey C.J., Park R., Benoist C., and Mathis D. The molecular program induced in T cells undergoing homeostatic proliferation. Proc Natl Acad Sci USA 101 (2004) 16885-16890
9. Sallusto F., Geginat J., and Lanzavecchia A. Central memory and effector memory T cell subsets: function, generation, and maintenance. Annu Rev Immunol 22 (2004) 745-763
10. + T-cell differentiation in response to viruses. Nat Rev Immunol 3 (2003) 931-939
11. + T lymphocytes. J Immunol 178 (2007) 4112-4119
12. + T cells expressing the lymph node-homing chemokine receptor CCR7 increases incidence and severity of acute graft-versus-host disease in patients undergoing allogeneic stem cell transplantation for hematologic malignancy. Leukemia 20 (2006) 1557-1565
13. + T-cell subsets in bone marrow and G-CSF-mobilized peripheral blood stem cell allografts: impact of donor characteristics. Exp Hematol 35 (2007) 861-871
14. Alizadeh M., Bernard M., Danic B., et al. Quantitative assessment of hematopoietic chimerism after bone marrow transplantation by real-time quantitative polymerase chain reaction. Blood 99 (2002) 4618-4625
15. + compartment. Mech Ageing Dev 127 (2006) 274-281
16. Kim H.T. Cumulative incidence in competing risks data and competing risks regression analysis. Clin Cancer Res 13 (2007) 559-565
17. Hakki M., Riddell S.R., Storek J., et al. Immune reconstitution to cytomegalovirus after allogeneic hematopoietic stem cell transplantation: impact of host factors, drug therapy, and subclinical reactivation. Blood 102 (2003) 3060-3067
18. Storek J., Dawson M.A., Storer B., et al. Immune reconstitution after allogeneic marrow transplantation compared with blood stem cell transplantation. Blood 97 (2001) 3380-3389
19. + T cells is induced by IL-2 receptor gamma chain signalling cytokines and type I IFN, and increases susceptibility to activation-induced apoptosis. Int Immunol 12 (2000) 1005-1013
20. + memory T cells mediated by IL-15 and its induced cytokines. J Immunol 177 (2006) 7802-7810
21. + subset reveals multiple homeostatic T-cell compartments with distinct implications for immune competence. Immunology 106 (2002) 27-37
22. + T cells in alemtuzumab-depleted kidney transplant recipients treated with reduced immunosuppression. Am J Transplant 8 (2008) 338-347
23. Abrahamsen I.W., Sømme S., Heldal D., Egeland T., Kvale D., and Tjønnfjord G.E. Immune reconstitution after allogeneic stem cell transplantation: the impact of stem cell source and graft-versus-host disease. Haematologica 90 (2005) 86-93
24. Baron F., Storer B., Maris M.B., et al. Unrelated donor status and high donor age independently affect immunologic recovery after nonmyeloablative conditioning. Biol Blood Marrow Transplant 12 (2006) 1176-1187
25. Ishaqi M.K., Afzal S., Dupuis A., Doyle J., and Gassas A. Early lymphocyte recovery post-allogeneic hematopoietic stem cell transplantation is associated with significant graft-versus-leukemia effect without increase in graft-versus-host disease in pediatric acute lymphoblastic leukemia. Bone Marrow Transplant 41 (2008) 245-252
26. + effector memory cells relative to central memory cells. Blood 103 (2004) 3986-3988
27. + memory T cells in allogeneic hematopoietic stem cell transplant recipients: chronic graft-versus-host disease enhances T cell differentiation and exhausts central memory T cell pool. Biol Blood Marrow Transplant 13 (2007) 1176-1184
28. + central memory cells associated with chronic graft-versus-host disease improve after extracorporeal photopheresis. Biol Blood Marrow Transplant 12 (2006) 22-30
29. EMRA) in chronic graft-versus-host disease. Leukemia 20 (2006) 545-547
30. + cells in patients with graft-versus-host disease after allogeneic bone marrow transplantation. Bone Marrow Transplant 13 (1994) 181-185
31. + T cells in whole blood versus PBMC samples. J Immunol Methods 309 (2006) 192-199
32. Baccala R., and Theofilopoulos A.N. The new paradigm of T-cell homeostatic proliferation-induced autoimmunity. Trends Immunol 26 (2005) 5-8
33. O'Keefe C.L., Gondek L., Davis R., et al. Molecular analysis of alloreactive CTL post-hemopoietic stem cell transplantation. J Immunol 179 (2007) 2013-2022
34. Beck R.C., Wlodarski M., Gondek L., et al. Efficient identification of T-cell clones associated with graft-versus-host disease in target tissue allows for subsequent detection in peripheral blood. Br J Haematol 129 (2005) 411-419
35. + T cells after allogeneic BMT is related with a low incidence of relapse and with cytomegalovirus infection. Br J Haematol 90 (1995) 300-730
36. Bacigalupo A., Vitale V., Corvò R., et al. The combined effect of total body irradiation (TBI) and cyclosporin A (CyA) on the risk of relapse in patients with acute myeloid leukaemia undergoing allogeneic bone marrow transplantation. Br J Haematol 108 (2000) 99-104